LAURENE REDDING, Global Head Strategic Pricing, BeiGene

•   With over 25 years of experience of progressively senior roles within the pharmaceutical industry, Laurene is currently the Global Head of Value, Access & Pricing at BeiGene. BeiGene is a global biotechnology company co-founded in 2010 by John Oyler, an American entrepreneur, and Dr. Xiaodong Wang, world renowned biochemist and youngest ever U.S. Academy of Science member, to deliver cancer medicines more broadly and improve the lives of patients worldwide.

•   Laurene’s experience spans both public and private healthcare, having worked early as her career as a health economic consultant, in the hospital system, as the head of the pharmaceutical division of Canada’s largest private insurer, and in various pharmaceutical companies. Laurene has also served as the industry representative on the Patented Medicines Prices Review Board (PMPRB), responsible for championing the industry’s views on price reform and modernization.